Fig 1.
Stilbenoid analogues of resveratrol.
Table 1.
Dosage groups for repeated dose 90 day oral toxicity study in SD rats.
Table 2.
Effect of 90 day oral administration of 3'-HPT on functional observation battery (neurobehavioural assessment) tests in male and female SD rats.
Table 3.
Effect of 90 day oral administration of 3'-HPT on haematology data of male and female SD rats.
Table 4.
Effect of 90 day oral administration of 3'-HPT on biochemical data of male and female SD rats.
Table 5.
Effect of 90 day oral administration of 3'-HPT on absolute organ weight (mg) of male and female SD rats.
Table 6.
Dosage groups for reproduction/developmental toxicity study in Wistar rats.
Fig 2.
Body weight changes on oral administration of 3'-HPT measured over 13 weeks (90 days) in male and female SD rats.
D1: Day one; W1, W5, W9 and W13: Week one, five, nine and thirteen. Data in Mean ± SD (n = 10/group).
Table 7.
Body weight of male and female pups (in g) during lactation in reproductive/developmental toxicity study of 3'-HPT in Wistar rats.
Table 8.
Absolute organ weights (in g) of animals upon 3'-HPT administration in reproductive/ developmental toxicity study of 3'-HPT in Wistar rats.
Table 9.
Corpora lutea and implantation sites in numbers in reproductive/ developmental toxicity study in Wistar rats.
Table 10.
Summary of effects of 3'-HPT administration on reproduction/development in Wistar rats.